Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on human prion disease.

Jonathan D F Wadsworth1, John Collinge

  • 1MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.

Biochimica Et Biophysica Acta
|April 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Prion propagation is controlled by discrete structural regions of PrP rather than overall stability.

The Journal of biological chemistry·2026
Same author

Modification of early behavioural, physiological and neuropathological endpoints by syntaxin-6 knockout in a humanised P301S transgenic model of tauopathy.

Acta neuropathologica·2026
Same author

High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure.

JAMA neurology·2026
Same journal

Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Molecular Basis of Disease Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

General Subjects Cumulative Contents.

Biochimica et biophysica acta·2020
Same journal

Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

Biochimica et biophysica acta·2019
Same journal

Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

Biochimica et biophysica acta·2019
Same journal

Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

Biochimica et biophysica acta·2019
See all related articles

Variant Creutzfeldt-Jakob disease (vCJD) is linked to bovine spongiform encephalopathy. Human prion disease diversity stems from distinct prion protein (PrP) isoforms, influencing disease characteristics and incubation periods.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epidemiology

Background:

  • Variant Creutzfeldt-Jakob disease (vCJD) shares a prion strain with bovine spongiform encephalopathy (BSE).
  • Understanding human prion diseases requires detailed molecular insights.
  • Prion diseases exhibit significant phenotypic diversity.

Purpose of the Study:

  • To investigate the molecular basis of phenotypic diversity in human prion diseases.
  • To understand the role of distinct prion protein (PrP) isoforms in disease characteristics.

Main Methods:

  • Analysis of extensive clinical, pathological, and molecular data from human prion disease patients.
  • Characterization of disease-related PrP isoforms and their physicochemical properties.

Related Experiment Videos

Main Results:

  • Phenotypic variation in human prion diseases is partly attributed to the propagation of PrP isoforms with differing physicochemical properties.
  • These distinct PrP isoforms influence disease presentation and progression.

Conclusions:

  • Distinct prion protein (PrP) isoforms are key drivers of human prion disease diversity.
  • Long incubation periods (over 50 years) complicate prediction of vCJD epidemic extent.